User profiles for Andrea Collins

Andrea Collins

- Verified email at lstmed.ac.uk - Cited by 12357

andrea Collins

- Verified email at cardiff.ac.uk - Cited by 2320

Assessing the environmental impacts of mega sporting events: Two options?

A Collins, C Jones, M Munday - Tourism management, 2009 - Elsevier
At a time when public and private agencies recognise the importance of sustainable
development, the environmental impacts of mega sporting events are commanding increasing …

Assessing the environmental consequences of major sporting events: The 2003/04 FA Cup Final

A Collins, A Flynn, M Munday, A Roberts - Urban studies, 2007 - journals.sagepub.com
Policy-makers are increasingly interested in the wider ramifications of sporting events,
including the environmental impacts of event visitation. This paper demonstrates how two …

Guest editorial: Perspectives on sustainable consumption

K Peattie, A Collins - International Journal of Consumer Studies, 2009 - Wiley Online Library
The typical guest editorial within a special issue of a journal will explain the theme of the
special issue, introduce the different contributions that follow, outline the contributions that each …

[HTML][HTML] Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South …

…, QE Bhorat, S Bibi, C Briner, P Cicconi, AM Collins… - The Lancet, 2021 - thelancet.com
Background A safe and efficacious vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of …

[HTML][HTML] Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a …

…, S Bibi, C Briner, P Cicconi, EA Clutterbuck, AM Collins… - The Lancet, 2021 - thelancet.com
Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency
use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, …

[HTML][HTML] Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised …

…, P Cicconi, S Charlton, EA Clutterbuck, AM Collins… - The Lancet, 2021 - thelancet.com
Background A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of
COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy …

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a …

…, JC Cameron, S Charlton, EA Clutterbuck, AM Collins… - The Lancet, 2021 - thelancet.com
Background Use of heterologous prime-boost COVID-19 vaccine schedules could facilitate
mass COVID-19 immunisation. However, we have previously reported that heterologous …

Measuring and managing the environmental impact of festivals: The contribution of the Ecological Footprint

A Collins, C Cooper - Journal of Sustainable Tourism, 2017 - Taylor & Francis
This paper assesses the contribution of the Ecological Footprint as a method for estimating
the environmental impact of festivals. It responds to calls for more rigorous methods to assess …

[HTML][HTML] Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in …

…, JC Cameron, S Charlton, EA Clutterbuck, AM Collins… - The Lancet, 2022 - thelancet.com
Background Given the importance of flexible use of different COVID-19 vaccines within the
same schedule to facilitate rapid deployment, we studied mixed priming schedules …

[HTML][HTML] Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials …

…, N Byard, S Camara, LC Gutierrez, AM Collins… - The Lancet, 2021 - thelancet.com
Background COVID-19 vaccine supply shortages are causing concerns about compromised
immunity in some countries as the interval between the first and second dose becomes …